# Postdoctoral Research â€“ INSERM CRCT (2020â€“2023)
This section summarizes my work at the Cancer Research Center of Toulouse (CRCT),
focused on modeling tumorâ€“immune interactions, transcriptomics, and integrative bioinformatics.

## **1. ModÃ©lisation multi-agents de lâ€™Ã©cosystÃ¨me tumoral (iScience 2023)**

<p align="center">
  <img src="figures/tumor_ecosystem_modeling.png" width="520px">
</p>

### **Objectif scientifique**  
Simuler lâ€™Ã©volution spatio-temporelle de tumeurs solides en incluant dynamique immunitaire, gradients diffusifs et interactions intercellulaires.

### **Contributions**
- Conception du modÃ¨le multi-agents (NetLogo).  
- Automatisation de centaines de simulations via OpenMOLE.  
- Analyse de sensibilitÃ©, exploration paramÃ©trique, extraction de mÃ©triques.  
- Production de figures utilisÃ©es dans lâ€™article iScience.

---

## **2. Polarisation macrophagique dans la leucÃ©mie lymphoÃ¯de chronique**

<p align="center">
  <img src="figures/macrophage_polarization.png" width="520px">
</p>

### **Objectif scientifique**  
Comprendre la transition des macrophages vers un Ã©tat pro-tumoral (NLC) et identifier les programmes rÃ©gulationnels sous-jacents.

### **Contributions**
- Estimation de lâ€™activitÃ© de rÃ©gulateurs transcriptionnels.  
- Participation au modÃ¨le dynamique de polarisation.  
- Analyse multi-datasets et validation croisÃ©e.  

---

## **3. PrÃ©diction de la rÃ©ponse Ã  lâ€™immunothÃ©rapie â€” GEMDECAN**

<p align="center">
  <img src="figures/immunotherapy_prediction.png" width="520px">
</p>

### **Objectif scientifique**  
Identifier des signatures transcriptomiques robustes associÃ©es Ã  la rÃ©ponse Ã  lâ€™immunothÃ©rapie (NK cells).

### **Contributions**
- Construction de parties de la pipeline bulk RNAseq.  
- Quantification, normalisation, tests diffÃ©rentiels (DESeq2).  
- InfÃ©rence TF activity (DoRothEA, VIPER).  
- ModÃ©lisation expression â†” rÃ©ponse thÃ©rapeutique.

---

## **4. Analyse du microenvironnement tumoral â€” LungPredict**

<p align="center">
  <img src="figures/lungpredict_deconvolution.png" width="520px">
</p>

### **Objectif scientifique**  
CaractÃ©riser la composition cellulaire et les programmes transcriptionnels des tumeurs pulmonaires afin dâ€™identifier les signaux associÃ©s Ã  lâ€™Ã©volution clinique.

### **Contributions**
- PrÃ©traitement complet RNAseq : QC â†’ trimming â†’ alignement â†’ quantification.  
- DÃ©convolution immunitaire (EPIC, CIBERSORTx).  
- Profilage rÃ©gulationnel.  
- Contribution Ã  lâ€™analyse intÃ©grÃ©e du microenvironnement.

---
# **5. Drug Repurposing for COVID-19 through Network Medicine**

[AccÃ©der au dossier du projet](./05_covid_network_medicine/)

**Affiliation:** INSERM U1037 â€“ Centre de Recherches en CancÃ©rologie de Toulouse (CRCT)  
**Period:** 2020â€“2021  
**Publication:** [Network and Systems Medicine, 2020](https://www.liebertpub.com/doi/10.1089/nsm.2020.0011)


## ðŸ§­ Context
At the onset of the COVID-19 pandemic, identifying potential therapeutic candidates required integrative strategies beyond single-target screening.  
This project used **network medicine** approaches to explore interactions between SARS-CoV-2 proteins, host cellular pathways, and drug targets, with the goal of repositioning existing compounds.  


## ðŸŽ¯ Objectives
- Integrate multi-omics and molecular interaction data to construct a **virusâ€“hostâ€“drug network**.  
- Identify biologically plausible drug candidates through **topological proximity** and **pathway enrichment**.  
- Test robustness of network-based predictions using simulated perturbations.  


## ðŸ§ª Methods
- **Data integration:** Hostâ€“virus interactome from public datasets (BioGRID, IntAct), drugâ€“target relationships from DrugBank and ChEMBL.  
- **Network modeling:** Weighted graph representation of molecular associations.  
- **Simulation:** Random rewiring and node removal to assess prediction stability.  
- **Analysis:** Centrality and community detection to highlight key druggable modules.  
- **Validation:** Cross-checking candidate lists with published clinical data and ongoing trials.  

## ðŸ’¡ Contributions
- Implemented random network simulations to evaluate robustness of predicted drugâ€“disease associations.  
- Automated analysis of node connectivity and topological metrics for ranking candidate drugs.  
- Contributed to visualization and reporting of systemic network perturbations.  
- Participated in manuscript review and interpretation of results.  

## ðŸ“˜ Key Skills
Network biology Â· Data integration Â· Graph theory Â· Drug repurposing Â· Python/R scripting  

## ðŸ”— Reference
*Verstraete N.*, et al. *CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.*  
*Network and Systems Medicine*, 2020. [DOI:10.1089/nsm.2020.0011](https://www.liebertpub.com/doi/10.1089/nsm.2020.0011)

---

## **6. Effets systÃ©miques du SARS-CoV-2**

<p align="center">
  <img src="figures/sarscov2_systemic.png" width="520px">
</p>

### **Objectif scientifique**  
DÃ©crire comment les protÃ©ines virales perturbent les fonctions cellulaires dans diffÃ©rents tissus, et caractÃ©riser les effets systÃ©miques.

### **Contributions**
- Analyses GO/Reactome/WikiPathways.  
- Identification de processus perturbÃ©s.  
- Contribution aux figures mÃ©canistiques.

---

## **7. Dynamique clonale & single-cell RNAseq**

<p align="center">
  <img src="figures/scRNA_clonality.png" width="520px">
</p>

### **Objectif scientifique**  
Ã‰valuer comment des clones tumoraux se diversifient sous traitement, et relier trajectoires transcriptomiques et rÃ©sistance Ã©mergente.

### **Contributions**
- Pipeline scRNA-seq : filtrage, normalisation, clustering, UMAP.  
- IntÃ©gration barcodes â†’ clones â†’ programmes transcriptionnels.  
- Analyse de la diversitÃ© clonale et trajectoires dâ€™Ã©tats.  

---
